Spartan Planning & Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
+2,344
New +$209K 0.16% 69
2026
Q1
Sell
-2,728
Closed -$217K 77
2025
Q4
$217K Sell
2,728
-42
-2% -$3.31K 0.16% 77
2025
Q3
$209K Buy
+2,770
New +$190K 0.16% 75
2023
Q4
$65.9K Buy
835
+831
+20,775% +$59.1K 0.07% 123
2023
Q3
$279 Buy
+4
New +$283 ﹤0.01% 138
2022
Q4
Sell
-718
Closed -$68K 170
2022
Q3
$68K Buy
718
+269
+60% +$26.6K 0.09% 44
2022
Q2
$42K Sell
449
-115
-20% -$11.2K 0.06% 62
2022
Q1
$57K Buy
+564
New +$59.3K 0.07% 82

Other funds holding CVS

Spartan Planning & Wealth Management's CVS Position: Q2 2026 in Review

Spartan Planning & Wealth Management opened a new position in CVS Health (CVS) in Q2 2026: 2,344 shares worth $243K. The stake represents 0.16% of the portfolio and ranks #69 among its holdings. This is a return to the name: Spartan Planning & Wealth Management previously reported a position in CVS as recently as Q4 2025.

Spartan Planning & Wealth Management first reported a position in CVS in Q1 2022 and has held it in 8 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Spartan Planning & Wealth Management held 2,344 shares of CVS Health worth $243K as of Q2 2026.
  • CVS Health was a new Spartan Planning & Wealth Management position in Q2 2026.
  • CVS Health made up 0.16% of Spartan Planning & Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Spartan Planning & Wealth Management first reported a position in CVS Health in Q1 2022 and has held it in 8 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Spartan Planning & Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.